Department of Pediatrics

Education

• BS, University of Illinois, 2006
• MD, Rush University, 2010
• MSCI, Washington University, 2018

Training

• Residency, University of Chicago, 2010 - 2013
• Fellowship, Washington University, 2014 - 2017

Licensure and Board Certification

• 2013 - 2023American Board of Pediatrics/General Pediatrics
• 2015 - PresMO, State of Missouri
• 2019 - 2029American Board of Pediatrics/Hematology Oncology

Honors and Awards

• Arnold P. Gold Foundation Humanism and Excellence in Teaching Award, 2013
• Ash Abstract Award, 2016
• David Gilstrap Award, 2017

Recent Publications view all (7)

Publication Co-Authors

Shalini Shenoy, M.D.

Todd Druley, M.D., Ph.D.

Jeffrey J. Bednarski, M.D., Ph.D.

Laura Schuettpelz, M.D, Ph.D.

Robert J. Hayashi, M.D.

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Sima Bhatt

1. Wong WH, Bhatt S, Trinkaus K, Pusic I, Elliott K, Mahajan N, Wan F, Switzer GE, Confer DL, DiPersio J, Pulsipher MA, Shah NN, Sees J, Bystry A, Blundell JR, Shaw BE, Druley TE. Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation. Sci Transl Med. 2020;12(526). PMID:31941826 
2. Bhatt ST, Schulz G, Hente M, Slater A, Murray L, Shenoy S, Bednarski JJ. A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease. Pediatr Blood Cancer. 2019;e28030. PMID:31599480 
3. Bhatt ST, Bednarski JJ, Berg J, Trinkaus K, Murray L, Hayashi R, Schulz G, Hente M, Grimley M, Chan KW, Kamani N, Jacobsohn D, Nieder M, Hale G, Yu L, Adams R, Dalal J, Pulsipher MA, Haut P, Chaudhury S, Davis J, Jaroscak J, Andreansky M, Willert J, Shenoy S.. Immune Reconstitution and Infection Patterns Following Early Alemtuzumab and Reduced Intensity Transplantation for Non-Malignant Disorders in Pediatric Patients. BBMT. 2018. PMID:30321596 
4. Monlish DA, Bhatt ST, Duncavage EJ, Greenberg ZJ, Keller JL, Romine MP, Yang W, Aplan PD, Walter MJ, Schuettpelz LG. Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS. Blood. 2018;131(9):1032-1035. PMCID:PMC5833264  PMID:29358180 
5. Monlish DA, Bhatt ST, Schuettpelz LG. The Role of Toll-Like Receptors in Hematopoietic Malignancies. Front Immunol. 2016;7:390. PMCID:PMC5039188  PMID:27733853 
6. Herman AC, Monlish DA, Romine MP, Bhatt ST, Zippel S, Schuettpelz LG. Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms. Blood Cancer J. 2016;6:e437. PMCID:PMC5141360  PMID:27315114 
7. Bhatt ST, Hageman JR, Bartlett A, Trivedi K. A 12-week-old male with a 10-day history of fever. Pediatr Ann. 2014;43(5):e111-5. PMID:24877492